NetWorth
LeaderPortfolio
Baumbach
Erich von Baumbach
Rank #607
GERMANY•Healthcare•Pharma

Erich von Baumbach

Net Worth
$6.494B
0% (24h)
Erich von Baumbach is a German billionaire, deriving his wealth from Boehringer Ingelheim, the world's largest privately-owned pharmaceutical company. As an heir to the fortune, his lineage traces back to the company's founder, Albert Boehringer, who established the company in 1885. Erich von Baumbach, along with other family members, owns equal parts of the company. His source of wealth is Pharma and his estimated net worth is $6.6 billion as of March 2026. He is a member of the Shareholders' Committee.

How to read Erich von Baumbach's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Erich von Baumbach, we anchor the narrative to Pharma and Pharma, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $6.494B alongside global rank #607, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (GERMANY) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Erich von Baumbach is a German billionaire and a member of the von Baumbach family, whose wealth is rooted in Boehringer Ingelheim, the world's largest privately-owned pharmaceutical company. The company was founded by Albert Boehringer in 1885. Erich's lineage traces directly back to the founder, making him an heir to the family fortune.

Rise to Success

Erich von Baumbach's career is characterized by his role as a major family shareholder in the governance of Boehringer Ingelheim. He became a member of the Shareholder's Committee in 1992. The company's success is built on continuous, massive investment in R&D and scientific excellence. His wealth is secured by the immense, continuous profitability of the private enterprise, which employs over 50,000 people globally.

Key Business Strategies

The von Baumbach family, along with the Boehringer family, has maintained private ownership of the company, allowing them to focus on long-term, high-risk drug research in essential therapeutic areas like COPD, anti-coagulation, and type 2 diabetes. Boehringer Ingelheim is known for its innovations in respiratory medicine, animal health, and biopharmaceutical contract manufacturing. The company's commitment to research and development has led to breakthrough therapies in various medical fields.

Philanthropy

The Boehringer and von Baumbach families are deeply committed to philanthropy. The Boehringer Ingelheim Foundation funds scientific research and education.

Career Timeline

1992

Member of the Shareholders' Committee

Erich von Baumbach became a member of the Shareholders' Committee of Boehringer Ingelheim.

Philanthropic Impact

Scientific Research and EducationUndisclosed

Boehringer Ingelheim Foundation

Funds scientific research and education.

Key Business Ventures & Holdings

CompanyStakeValue
Boehringer Ingelheim——

Net Worth History

In-Depth Analysis

Early Life

Erich von Baumbach is a German billionaire and a member of the von Baumbach family, whose wealth is rooted in Boehringer Ingelheim, the world's largest privately-owned pharmaceutical company. The company was founded by Albert Boehringer in 1885. Erich's lineage traces directly back to the founder, making him an heir to the family fortune.

Rise to Success

Erich von Baumbach's career is characterized by his role as a major family shareholder in the governance of Boehringer Ingelheim. He became a member of the Shareholder's Committee in 1992. The company's success is built on continuous, massive investment in R&D and scientific excellence. His wealth is secured by the immense, continuous profitability of the private enterprise, which employs over 50,000 people globally.

Key Business Strategies

The von Baumbach family, along with the Boehringer family, has maintained private ownership of the company, allowing them to focus on long-term, high-risk drug research in essential therapeutic areas like COPD, anti-coagulation, and type 2 diabetes. Boehringer Ingelheim is known for its innovations in respiratory medicine, animal health, and biopharmaceutical contract manufacturing. The company's commitment to research and development has led to breakthrough therapies in various medical fields.

Philanthropy

The Boehringer and von Baumbach families are deeply committed to philanthropy. The Boehringer Ingelheim Foundation funds scientific research and education.

Data Sources & Methodology

Figures for Erich von Baumbach are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.

You may also like

HubAll BillionairesHubGlobal RankingsHubNewsroom